Clinical Trials Browser

trilaciclib × Gastrointestinal × Clear all

NCT04607668 2024-11-26

PRESERVE1

Phase 3 Terminated

326 enrolled 15 charts

Gastrointestinal

Colorectal Neoplasms

NCT06569459 2024-08-26

Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms